Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life

The transcript discusses the company's R&D spending, focusing on access and awareness programs for EpiPen. It highlights efforts to develop new devices based on patient feedback and improve the product's shelf life. The goal is to extend the shelf life to 24 months, with plans to submit findings to the FDA soon. Continued work on stability may further extend the shelf life beyond 24 months.

What is the primary focus of the company's R&D spending for EpiPen?

• Access and awareness programs

• Developing new flavors

• Reducing production costs

• Marketing campaigns

What is the current shelf life of the EpiPen?

• 18 months

• 12 months

• 6 months

• 24 months

What is the company's target shelf life for the EpiPen?

• 30 months

• 24 months

• 18 months

• 12 months

When does the company plan to submit their findings to the FDA?

• Next year

• In a few days

• In a few weeks

• In a few months

What will the company continue to work on after submitting to the FDA?

• New product lines

• Cost reduction

• Marketing strategies

• Stability of the product